GeneDx
Market cap
$1.927 B
$64.62 -6.81%
Close of 6 Nov 2026
As of 6 Nov 2026, GeneDx (WGS) has a market capitalization of $1.93B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
$427.5M
#1975 by revenue
Earnings
-$21.0M
Loss-making
Shares outstanding
29,822,541
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Medical/Nursing Services, ranked by market cap
All 29 →- #7Aveanna HealthcareAVAH$2.99B
- #8Addus HomeCareADUS$2.36B
- #9GeneDxWGS$1.93B
- #10Teladoc HealthTDOC$1.72B
- #11U S Physical TherapyUSPH$1.45B
What if GeneDx were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for GeneDx are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.